Previous Close | 199.30 |
Open | 197.82 |
Bid | 0.00 x 20000 |
Ask | 0.00 x 20000 |
Day's Range | 197.82 - 197.82 |
52 Week Range | 172.78 - 228.35 |
Volume | |
Avg. Volume | 2 |
Market Cap | 38.964B |
Beta (5Y Monthly) | 0.44 |
PE Ratio (TTM) | 23.69 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | 1.82 (0.92%) |
Ex-Dividend Date | Aug 09, 2024 |
1y Target Est | N/A |
CONSHOHOCKEN, Pa., October 01, 2024--Cencora, Inc. (NYSE: COR) today announced that it plans to release its results for the Fourth Quarter of Fiscal 2024 on Wednesday, November 6, 2024, prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the results at 8:30 a.m. ET on November 6, 2024.
CONSHOHOCKEN, Pa., August 15, 2024--Cencora, Inc. (NYSE: COR) today announced that its Board of Directors has elected Frank Clyburn as a new independent director, effective October 1, 2024. With the election of Mr. Clyburn, the Board of Directors will increase to thirteen members.
CONSHOHOCKEN, Pa., August 01, 2024--Cencora, Inc. (NYSE: COR) today announced that it has agreed to repurchase shares of its common stock from Walgreens Boots Alliance Holdings LLC in the amount of approximately $250 million in concurrence with Walgreens Boots Alliance’s sale of Cencora shares pursuant to Rule 144 under the Securities Act of 1933, as amended.